Alfetim,
alfusozine,
alfuzosin,
alfuzosin hydrochloride,
alphuzosine,
Benestan,
N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide,
Urion,
UroXatral,
Xatral,
alfuzosin,
81403-80-7,
Alfuzosina,
Alfuzosine,
Alfuzosinum,
Alfuzosine [French],
Alfuzosinum [Latin],
Alfusosine,
Alfuzosina [Spanish],
Alfuzosin [INN:BAN],
ALFLUZOCIN,
SL 77499,
HSDB 7290,
SL 77-499,
CHEMBL709,
CHEBI:51141,
WNMJYKCGWZFFKR-UHFFFAOYSA-N,
N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide,
N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide,
C19H27N5O4,
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide,
alphuzosine,
N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide,
Alfuzosin (INN),
2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-,
SMR000466340,
Xatral (TN),
SL-77499-10,
Alfuzosin/,
N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl),
SR-01000759345,
n-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide,
ALFLUZOSIN,
AC1L1CWF,
Prestwick0_000322,
Prestwick1_000322,
Prestwick2_000322,
Prestwick3_000322,
Spectrum2_000505,
Spectrum3_001063,
Spectrum4_001208,
Spectrum5_000817,
SCHEMBL34477,
BSPBio_000323,
BSPBio_002646,
KBioGR_001616,
MLS000759449,
MLS001424027,
MLS006011887,
SPECTRUM1505263,
SPBio_000429,
SPBio_002244,
BPBio1_000357,
GTPL7109,
DTXSID6048549,
KBio3_001866,
HMS1922P11,
HMS2051I10,
HMS2093O06,
HMS2235O22,
HMS3369K03,
HMS3393I10,
Pharmakon1600-01505263,
ACT03219,
HY-B0192,
ABP000595,
BDBM50033110,
BG0022,
CCG-39585,
MFCD00865792,
NSC760065,
STK643675,
AKOS005574697,
API0001406,
CCG-100859,
CS-2086,
DB00346,
MCULE-9094645643,
NC00109,
NSC-760065,
VA10203,
NCGC00095152-01,
NCGC00095152-02,
NCGC00095152-03,
NCGC00095152-04,
NCGC00095152-05,
NCGC00095152-07,
AN-36345,
CC-23834,
CPD000466340,
K449,
LS-70106,
SAM001246638,
SC-17006,
SBI-0206735.P001,
AB0014226,
AB00514667,
FT-0630891,
D07124,
AB00514667-07,
AB00514667-09,
AB00514667-10,
AB00514667_11,
AB00514667_12,
(methyl)amino)propyl)tetrahydrofuran-2-carboxamide,
403A807,
A840122,
C-21524,
L001317,
SR-01000759345-4,
BRD-A09056319-001-02-2,
BRD-A09056319-001-05-5,
BRD-A09056319-003-03-6,
N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-methylamino]propyl]-2-oxolanecarboxamide,
N-[3-[(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxolane-2-carboxamide,
N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide,
(+/-)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide,
2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-,
N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide,
N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide,
N-[3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)methylamino]propyl]tetrahydrofuran-2-carboxamide,
N-{3-[(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboximidic acid,
Uroxatral,
Xatral,
Alfuzosin HCl,
Alfuzosin Hydrochloride,
Uroxatral (TN),
D09MWJ,
UNII-90347YTW5F,
CID2092,
90347YTW5F,
SL 77,
C19-H27-N5-O4,
CS-O-05655,
1683B,
SL-7749910,
81403-68-1,
N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuroyl-2)-propylenediamine,